Next 10 |
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board Recently announced capital raise plan of $500+ million utiliz...
Terry Rafih to remain as Executive Chairman of the Board Appointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well as its greenhouse expansion plans The Company confirms the receipt of i...
GRANTS, N.M., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and c...
GRANTS, N.M., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cann...
Bright Green acquired 25% of Alterola’s issued and outstanding common stock Acquisition will support Bright Green’s ability to manufacture and distribute federally compliant, pharmaceutical-grade cannabis and derivatives Acquisition of remaining Alterola st...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com It’s time for another breakdown of the biggest pre-market stock movers as we cover what’s moving shares on Thursday morning! We’ve got initial public offeri...
Cannabis company Bright Green ( NASDAQ: BGXX ) has signed a letter of intent with the U.K.-based pharmaceutical company Alterola Biotech ( OTCPK:ABTI ) to purchase the latter's issued and outstanding common stock. BGXX will initially purchase 25% of Alte...
Bright Green to acquire 25% of Alterola common stock, followed by proposed acquisition of all remaining Alterola common stock, subject to customary conditions and regulatory and stockholder approvals Partnership with Alterola will support Bright Green’s ability to manufac...
CannaInvestor Magazine Launches New Magazine - PharmaInvestor Magazine ATLANTA, GA / ACCESSWIRE / April 20, 2022 / Alterola Biotech, Inc. ( OTC PINK:ABTI ) a UK based pharmaceutical company will be the featured company in the new PharmaInvestor Magazine May 2022 Issue. Despite the downt...
BIRKENHEAD, UK / ACCESSWIRE / February 24, 2022 / The Board of Directors (the "Board") of Alterola Biotech, Inc. (OTC PINK:ABTI) or (the "Company") is pleased to announce that the Company has filed an application to upgrade from the OTC PINK tier to the OTCQB tier of OTC Markets. Tim Rogers...
News, Short Squeeze, Breakout and More Instantly...
Alterola Biotech Inc Company Name:
ABTI Stock Symbol:
OTCMKTS Market:
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board Recently announced capital raise plan of $500+ million utiliz...
Terry Rafih to remain as Executive Chairman of the Board Appointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well as its greenhouse expansion plans The Company confirms the receipt of i...
GRANTS, N.M., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and c...